Cocooncenter has been acquired by Groupe Pharmacie Lafayette
The shareholders of Cocooncenter have sold the company to Groupe Pharmacie Lafayette.
Founded in 2005, Cocooncenter offers an assortment of parapharmaceutical products from the leading laboratory brands, dedicated to well-being. The offer includes more than 720 brands and more than 24,000 references selected by a team of specialists to guarantee product quality. Cocooncenter has put customer relations at the heart of its strategy with a dedicated service providing personalized advice and satisfaction monitoring.
Groupe Pharmacie Lafayette, owned by the fund Five Arrows Principal Investments, has been working since 2005 to make healthcare accessible to all through its four brands: Pharmacie Lafayette, Parapharmacie Lafayette, Optique Lafayette and Lafayette Medical. The group has developed a network of pharmacies that offer low prices on very wide range of products, as well as professional advice.
Oaklins’ team in France acted as advisor to the shareholders of Cocooncenter in this transaction.
Talk to the deal team
Ricotto has been acquired by Sitra Group
Ricotto S.r.l. has joint Sitra Group, a Belgium-based and PE-backed international logistic and transportation group.Learn more
M80 Partners has acquired Luminis
Belgian private equity fund M80 has acquired a majority stake in Luminis. M80 offers to software and technology company Luminis the opportunity to further expand its strategy and market position internationally. Luminis becomes part of a platform that also includes XPLUS, a Belgian expert in enterprise IT architecture. M80 plans to make further selective acquisitions in Europe in the coming months with the aim of bringing together a portfolio of best-in-class digital transformation specialists.Learn more
Spice Private Equity Ltd. has had a fairness opinion conducted on a public tender offer by GP Investments
On 14 July 2022, GP Swiss Ltd., a subsidiary of GP Investments, published a public tender offer for all publicly held registered shares of Spice Private Equity Ltd. (Spice). The independent members of the Board of Directors of Spice have had a fairness opinion conducted on the financial adequacy of this public tender offer. The offer price for each Spice share was US$16.25 net in cash. Following a successful offer, GP Investment intends to delist the stock from the SIX Swiss Stock Exchange.Learn more